Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 10, 2026, 12:24 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2497–2520 of 2,544 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Parasomnia Clear all

Conditions: Sleep Apnea, Obstructive
Interventions: Portable sleep monitor, In-laboratory Polysomnography; Device · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 5 Years to 12 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Sleep Disturbance, Poor Sleep Quality, Insomnia (Self-reported, Non-diagnosed)
Interventions: Sleep Gummy Intervention; Dietary Supplement
Lead sponsor: DTBE, LLC dba FlavCity; Industry
Eligibility: 20 Years to 50 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Insomnia
Interventions: pCBT-I; Behavioral
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Novi, Michigan

Conditions: Obstructive Sleep Apnea, Obesity
Interventions: Laparoscopic Gastric Banding, Continuous Positive Airway Pressure; Procedure
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 65 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Opiod Use Disorder, Obstructive Sleep Apnea
Interventions: Not listed
Lead sponsor: University of California, San Diego; Other
Eligibility: 45 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: San Diego, California

Conditions: Chronic Insomnia
Interventions: Zolpidem, Internet Cognitive Behavioral Therapy for Insomnia (CBT-I), Trazodone; Drug · Behavioral
Lead sponsor: California Pacific Medical Center Research Institute; Other
Eligibility: 18 Years to 80 Years
Enrollment: 155 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 7
States / cities: Birmingham, Alabama • Tucson, Arizona • Columbia, Missouri + 4 more

Conditions: Obstructive Sleep Apnea
Interventions: PAP therapy, Sham PAP therapy; Device
Lead sponsor: University of Tennessee; Other
Eligibility: 6 Years to 12 Years
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2016
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: Obstructive Sleep Apnea
Interventions: budesonide and montelukast, Placebo; Drug
Lead sponsor: Romaker & Associates; Other
Eligibility: 18 Years to 100 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 2
States / cities: Kansas City, Missouri

Conditions: Cleft Palate
Interventions: Polysomnography; Procedure
Lead sponsor: University of Michigan; Other
Eligibility: 6 Years to 15 Years
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Obstructive Sleep Apnea
Interventions: Mandibular advancement device (MAD); Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 70 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Obstructive Sleep Apnea, Sleep Apnea, Sleep Apnea, Obstructive, Sleep, Sleep Disorder
Interventions: Eszopiclone, Supplemental Oxygen, Continuous Positive Airway Pressure (CPAP); Drug · Other · Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 21 Years to 65 Years
Enrollment: 233 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2026
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Hemoglobinuria, Paroxysmal
Interventions: Not listed
Lead sponsor: University of Utah; Other
Eligibility: 7 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Major Depressive Disorder, Insomnia
Interventions: escitalopram and eszopiclone, Escitalopram, eszopiclone, and placebo, Escitalopram; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 64 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Insomnia, COPD, Chronic Obstructive Pulmonary Disease, Fatigue
Interventions: Cognitive Behavioral Therapy for Insomnia, COPD Education, Attention Control; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 45 Years and older
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Adenovirus, Anesthesia, Anxiety, Anxiolysis, Autism, Autistic Disorder, Bacterial Meningitis, Bacterial Septicemia, Benzodiazepine, Bipolar Disorder, Bone and Joint Infections, Central Nervous System Infections, Convulsions, Cytomegalovirus Retinitis, Early-onset Schizophrenia Spectrum Disorders, Epilepsy, General Anesthesia, Gynecologic Infections, Herpes Simplex Virus, Infantile Hemangioma, Infection, Inflammation, Inflammatory Conditions, Intra-abdominal Infections, Lower Respiratory Tract Infections, Migraines, Pain, Pneumonia, Schizophrenia, Sedation, Seizures, Skeletal Muscle Spasms, Skin and Skin-structure Infections, Treatment-resistant Schizophrenia, Urinary Tract Infections, Withdrawal, Sepsis, Gram-negative Infection, Bradycardia, Cardiac Arrest, Cardiac Arrhythmia, Staphylococcal Infections, Nosocomial Pneumonia, Neuromuscular Blockade, Methicillin Resistant Staphylococcus Aureus, Endocarditis, Neutropenia, Headache, Fibrinolytic Bleeding, Pulmonary Arterial Hypertension, CMV Retinitis, Hypertension, Chronic Kidney Diseases, Hyperaldosteronism, Hypokalemia, Heart Failure, Hemophilia, Heavy Menstrual Bleeding, Insomnia
Interventions: The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care:; Drug
Lead sponsor: Daniel Benjamin; Other
Eligibility: Up to 21 Years
Enrollment: 3,520 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2019
U.S. locations: 43
States / cities: Anchorage, Alaska • Little Rock, Arkansas • La Jolla, California + 37 more

Conditions: Restless Legs Syndrome
Interventions: Not listed
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 68 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Breast Cancer, Insomnia, Weight Gain
Interventions: Cognitive-Behavioral Therapy for Insomnia (CBT-I), Sleep Education Control (EDU); Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 4
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland • Lutherville, Maryland

Conditions: Perceived Stress, Anxiety, Sleep Disturbance
Interventions: "Calm" is a mindfulness meditation mobile app; Other
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Nocturia, Hypertension, Sleep Disturbance
Interventions: BBTI, PM antihypertensive dosing or Chronotherapy, AM antihypertensive dosing; Behavioral · Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 65 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Tonsillectomy Postoperative Adverse Events
Interventions: Not listed
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: Up to 17 Years
Enrollment: 2,400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Down Syndrome, Obstructive Sleep Apnea
Interventions: Family-informed intervention, Standard Clinical Care; Behavioral
Lead sponsor: University of Miami; Other
Eligibility: 6 Years to 18 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 3
States / cities: Miami, Florida • Cincinnati, Ohio • Philadelphia, Pennsylvania

Conditions: HIV, AIDS, Peripheral Neuropathy, Pain, Sleep
Interventions: Splinting application to the lower extremities, Splint liner application; Device
Lead sponsor: Texas Woman's University; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Fatigue, Stress, Burnout, Professional, Musculoskeletal Pain, Back Pain, Neck Pain, Headache, Dizziness, Sleep Disturbance, Chest Pain, Syncope, Cardiovascular Diseases, Shortness of Breath, Gastrointestinal Diseases
Interventions: Not listed
Lead sponsor: TMRW Life Sciences; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 246 participants
Timeline: 2022
U.S. locations: 1
States / cities: New York, New York

Conditions: REM Behavior Disorder, Parkinson Disease
Interventions: Not listed
Lead sponsor: CND Life Sciences; Other
Eligibility: 50 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 18
States / cities: Scottsdale, Arizona • Irvine, California • Los Angeles, California + 14 more

Search by objective public record fields.

Feasibility of Unattended Home Polysomnography and Comparison to In-laboratory Polysomnography in Pediatric Patients

A Trial to Examine the Efficacy of a Supplement Gummy to Improve Sleep Quality and Quantity

Preventing Insomnia With Virtual Oneshot Therapy (PIVOT)

Apnea, Bariatric Surgery Versus Continuous Positive Airway Pressure (CPAP) Trial

Effects of Mental Tasks on Breathing Patterns in Adults Using Chronic Opioids vs Non-opioid Users.

CBT-I or Zolpidem/Trazodone for Insomnia

Effects of Positive Airway Pressure (PAP) in Children With Obstructive Sleep Apnea (OSA)

Montelukast and Inhaled Nasal Steroid Tx in Adult Obstructive Sleep Apnea (OSA)

Sleep and Behavior in Children With Cleft Palate

Reducing Obstructive Sleep Apnea After Hypoglossal Nerve Stimulation Through Mandibular Advancement

Do Endotypes Predict Response and Sequelae in OSA Patients

The Molecular Biology of Paroxysmal Nocturnal Hemoglobinuria (PNH)

Brain Mechanisms and Targeting Insomnia in Major Depression

A Behavioral Therapy for Insomnia Co-existing With COPD

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

Suggested Immobilization Test (SIT) Test for Early Detection of Restless Legs Syndrome (RLS) Augmentation - Proof of Concept

The Effects of Treating Insomnia on Behavioral Weight Loss Outcomes in Survivors of Breast Cancer

Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic

Sleep, Hypertension, and Nocturia: a Multicomponent Approach for Comorbid Illnesses

Factors Predictive of Adverse Postoperative Outcomes in Children Undergoing Tonsillectomy

Positive Airway Pressure (PAP) for Children With Down Syndrome (DS) and Obstructive Sleep Apnea Syndrome (OSAS)

Lower Extremity Splinting to Manage Pain and Sleep Disturbances Associated With HIV/AIDS Related Peripheral Neuropathy

The U.S. Embryologist Fatigue Study

Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease